Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
An analyst gave a price target of 8$
At the end of the day you were right about something. But I don’t think they wanted it to go this way, they fuked up. Let’s see if they can fix it.
Give it to 8/29..
Unless I am mistaken, this clause in the most recent 8k amends earlier provisions for certain audits to be filed by certain dates. Though previous 8k’s said it
Needed to be done by a certain date or the subsidiaries would return to SOLI, unless AMENDED, this recent 8k shows they voted to withdraw any commitment to a certain date.
To me, it says they are still having trouble w logistics…dear god, they have had enough time to resolve!
On May 2, 2022, the Board of Directors of Registrant approved an Amended Management Operating Agreement, removing all further conditions to the Final Closing except the obligation to register and issue the balance of the share consideration, and removing a rescission provision in the event that certain conditions were not met by May 31, 2022. Registrant has
The final sentence.. “removing a rescission….”
Trying to stay positive here.
The contract said that operational closing would be done before the final closing. The final closing is not effective until s4 is effective. And if it does not finalize, all subsidiaries go back to SOLI.
Not sure how that would go.
Anyway, no one gets their shares including the fired former officers of life on earth unless this goes through. Call me crazy but I don’t think this delay is scam related…I think they are still having problems w logistics whether dealing w audit or acquisition.
I guess I’m just being optimistic at this point. I’m not delusional
The filing date of the report was 5/5 , so perhaps a bit longer? I really hope they get this done..
There new fiscal year just ended 5/31
What we are looking for now is a year end audited 10k
If we see that, we will see submission of an s4 to the sec pretty quick.
Then we wait for our shares
75/25
Until the shares get transferred, it’s not gonna move imo. However, once the deal is done we could see very strong movement. That’s my hope. Let’s start w an s-4 first week of June.
Yeah, from what I’ve read, there could be some more waiting after s-4 has been submitted.
I think there is a reasonable chance we see an audited 10-k first week of June, and an S4 filing shortly after that..perhaps they were just waiting for the fiscal year to end to submit the completed audits in whole.
The share consideration, a total of 300 million shares of Registrant’s common stock, have been reserved for issuance as soon as the shares are registered on Form S-4, which is expected to be filed immediately upon filing of Registrant’s Form 10-K Annual Report for its fiscal year ended May 31, 2022
Annual revenue projection is 3 times our market cap.. this is going up.. unfortunately we are
In a down market. Let’s see.. I think we go up tmrw and stay over 3$ for good.
June. Sorry.
So the S4 going to be filed first week of April most likely.
This phrase has my attention:
. This will allow LFER to engage with the right sponsor(s) in order to help LFER up list the company this year
Sponsor ? Like SPAC?
It was part of an 8k, written in January, signed by ceo of LFER. Here is the whole thing.
https://www.sec.gov/Archives/edgar/data/1579010/000101738622000031/exhibit_99-1.htm
The Next three quarters and Our Ultimate Goal:
Our ultimate goal is to be the company known for Cloud based software and technology and enable secure solutions for the world Telehealth platform of services in Digital healthcare and Telemonitoring.
As we finalize the CareClix acquisition we are taking the last steps of fully consolidating our companies which include filing an S4 registration, electing new board members, integration of the management teams, enhancing the software, portfolio of services and expanding our market position worldwide. Our plans will be focused on our Telehealth platform, digital healthcare, remote patient monitoring, personal consultative medical services firmly grounded on our software technology platform with PaaS and SaaS offerings. In this vein, we are engaging outside parties to help scale the CareClix businesses, both organically and possibly through further M&A. This will allow LFER to engage with the right sponsor(s) in order to help LFER up list the company this year.
When I joined the Company in February 2021, my goal, and the reason why I got involved with my own personal investment, was to clear the path to up-list the Company to either the NASDAQ or the NYSE. As we continue with this strategy, we will make periodic announcements about our progress.
LFER
Let me briefly describe the CareClix businesses which are now subsidiaries of LFER:
1. CareClix, Inc:
CareClix, Inc is a digital healthcare development company centered around the CareClix® virtual telehealth platform. The CareClix Anywhere™ platform was originally created in 2012 by physicians for physicians and, throughout its 10-year history, development has been led by licensed and practicing physicians—making CareClix® a unique virtual healthcare delivery platform. Currently the CareClix® virtual telehealth platform is recognized worldwide as one of the most complete telehealth platforms for medical service providers.
2. CareClix Services Inc:
CareClix Services Inc is a leading telemedicine solutions firm which combines software applications and a multispecialty medical network for a wide variety of health care services stakeholders. By combining the software platform with medical services, CareClix is revolutionizing the way hospitals, doctors, and clinical care providers can interact with an increasing number of patients with increasing amounts of data. CareClix' suite of services is trusted by some of the best names in healthcare with more than 20 million individuals in the U.S. and 35 other countries currently having access to CareClix' telehealth platform or services.
3. MyCareClix, Inc:
MyCareClix is a direct-to-consumer family health and wellness company. Starting in early 2022, MyCareClix will be offering the suite of CareClix services directly to consumers. For a small monthly subscription fee, both individual and family consumers in the US will have access to the CareClix Network of primary care and specialty doctors, as well as access to testing, prescriptions, and ship-to-home medical products
4. CareClix RPM, Inc:
CareClix RPM will distribute and monitor FDA approved healthcare devices for remote patient monitoring and chronic care management utilizing the CareClix Anywhere™ platform to track and report monitored patient data. CareClix RPM, Inc will create turnkey solutions for providers seeking to start or expand their remote patient monitoring, remote therapeutic monitoring or chronic care management programs. Beginning in 2022, CareClix RPM will procure and distribute devices and offer a multi-lingual patient engagement team with qualified medical oversight and thorough reporting for billing and care plan administration.
The long term issue was the soli audit. Soli out of the picture. This is the difference this time.
I’m not a lawyer , but your opinion does not seem to cut the legal mustard.
IF there were some shares that were not filed correctly, they and all soli shares have now been revoked.
Careclix decides to go somewhere else and start fresh. Clean slate
I think he is only talking about the shares that were allocated at inception of soli and careclix acquisition back in 2019 or whatever year it was..
Perhaps. But that is in the past now.
SOLI is not part of new audit.
If they can become profitable by end of year, this could be a great long term hold.
Heck, if anyone can handle another delay it is us!
Registrant was unable without unreasonable effort and expense to prepare its accounting records and schedules in sufficient time to allow its accountants to complete their review of the Registrant’s financial statements for the quarter ended February 28, 2022 before the required filing date for the Quarterly Report on Form 10-Q due to the acquisition of assets during the prior quarter, as well as the difficulty in integrating the disposition and discontinuation of subsidiary business operations into the financial statements. The Registrant intends to file the subject Quarterly Report on Form 10-Q on or before the fifth calendar day following the prescribed due date.
Added!
Just for fun.. let’s pretend all 40k physicians sign on.. multiply that times 25$ a month & then multiply that by 12 for an annual number.
When the shares get converted and we are trading at 25cents you will have your answer.
Their are no disillusioned shareholders selling their (Soli) shares because their shares are still stuck in Soli.
As far as I know, which is little, things are still moving along.
3.50$ close
I’m sure there are crazier stories but this ticker is worthy…
It is hard to imagine that all the steps done by both parties (cancellation of debt, cancellation of shares, letting go of subsidiaries) are being done for naught. They are certainly gonna go and file the S4 and I think all we need to worry about is if SEC approves.
I think it goes through, but it could take longer then we want.
We will get there..somehow, someway!
So this trades nearly 5 billion by lunch, and then stops cold turkey?
Ask ask up to 3
Good luck. Big gAp (up) Monday mrng imo.
Your shares will hopefully transfer into ticker symbol LFER. Not sure when.B4 May I imagine.
Good luck